CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr | ₹3,181 Cr |
What is the latest Operating Profit of CIPLA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹6,291 Cr |
| Mar2024 | ₹4,990 Cr |
| Mar2023 | ₹4,512 Cr |
| Mar2022 | ₹4,249 Cr |
| Mar2021 | ₹3,181 Cr |
How is Operating Profit of CIPLA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,291 Cr | 26.07 | |
| Mar2024 | ₹4,990 Cr | 10.60 | |
| Mar2023 | ₹4,512 Cr | 6.20 | |
| Mar2022 | ₹4,249 Cr | 33.57 | |
| Mar2021 | ₹3,181 Cr | - | |
Compare Operating Profit of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,435.6 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,806.8 Cr | 0.3% | 2.4% | -22.7% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.5% |
-1.5% |
-2.5% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses